Drug Trade Group Quietly Spends ‘Dark Money’ To Sway Policy And Voters
Grants by top pharma group to lightly regulated, politically active nonprofits dwarf its conventional campaign spending.
Health Industry
2,301-2,320 of 4,031 results
-
-
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Community Frets As Buyer For Cherished Rural Hospital Slips From View
Some residents of remote Surprise Valley in Northern California fear their hospital will close like so many others around the country, as hope wanes for financial support from a Denver entrepreneur. The businessman, Beau Gertz, had planned to raise money through lab billing for faraway patients.
-
Podcast: KHN’s ‘What The Health?’ Congress And Health Care. Again.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.
-
A Transgender Woman’s Quest For Surgery Caught In Political Crosswinds
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
-
A Transgender Woman’s ‘Bait-And-Switch’ $92,000 Surgery Bill
After being promised a significant discount for paying cash upfront and forgoing insurance, a Wisconsin patient gets caught in the middle between hospital and insurer — and feels snookered by a last-minute surprise and billing snafu.
-
Déjà Voodoo: Pharma’s Promises To Curb Drug Prices Have Been Heard Before
Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.
By Jay Hancock and Sarah Jane Tribble -
Time For That Colonoscopy? Probe Your Doc First On How The Scopes Are Cleaned
Millions of Americans undergo procedures each year requiring medical scopes, but there’s growing concern about the risk of infection from dirty devices. Be prepared to ask questions — and bail if you’re not satisfied with the answers.
By Emily Bazar -
Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
By Fred Schulte -
Hospitals Gear Up For New Diagnosis: Human Trafficking
Many people forced into labor or the sex trade seek medical help at some point, and health care workers are being trained to identify them to offer assistance.
-
Profiles For Sale: How Bits Of Captured Data Paint A Valuable Picture Of Your Health
Consumers, beware: Data brokers compile health and frailty profiles that have wide-ranging applications for drug companies, advertisers, insurers and other buyers.
By Rachel Bluth -
Can A Community Hospital Stay True To Its Mission After Sale To Large Corporation?
After 130 years as a nonprofit with deep roots in western North Carolina, Mission Health announced in March that it was seeking to be bought by HCA Healthcare, the nation’s largest for-profit hospital chain.
-
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Podcast: KHN’s ‘What The Health?’ Drug Prices And Unicorns
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Facebook Live: The Marketing Plan That Fueled An Addiction Epidemic
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma’s early OxyContin marketing plan.
-
Retooled Vaccine Raises Hopes As A Lower-Cost Treatment For Type 1 Diabetes
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
-
‘Like A Ghost Town’: Erratic Nursing Home Staffing Revealed Through New Records
Daily nursing home payroll records just released by the federal government show the number of nurses and aides dips far below average on some days and consistently plummets on weekends.
By Jordan Rau -
Insurers Fall Short In Catching And Reporting Medicaid Fraud, Inspectors Find
Medicaid has struggled for years with poor oversight and billions lost to improper payments. A new report finds that despite their fraud-fighting rhetoric, Medicaid managed-care companies are not as rigorous as they should be in ensuring the integrity of the Medicaid payment system.
By Chad Terhune -
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.